{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-003881","form_type":"8-K","ticker":"MGRX","cik":"0001938046","company_name":"MANGOCEUTICALS, INC.","filed_at":"2025-04-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.514029+00:00","generated_at":"2026-05-23T16:30:58.557276+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Mangoceuticals issues 335,000 fully-vested shares as 2025 discretionary bonus","bullets":["CEO Jacob Cohen received 200,000 shares; President Antonios Isaac received 60,000 shares.","Three directors (Myers, Hamilton, D'Alessio) each received 25,000 shares.","Shares issued under Second Amended and Restated 2022 Equity Plan on April 10, 2025.","Awards are fully vested and earned for services rendered during 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-003881","json":"https://secwatch.observer/filing/0001641172-25-003881.json","markdown":"https://secwatch.observer/filing/0001641172-25-003881.md","text":"https://secwatch.observer/filing/0001641172-25-003881.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938046/000164117225003881/0001641172-25-003881-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938046/000164117225003881/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T16:30:58.557276+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}